What is teriflunomide (and what does “EMA” mean here)?
Teriflunomide is an oral medicine used to treat multiple sclerosis (MS). When people search “teriflunomide EMA,” they usually want the European Medicines Agency (EMA) information: the approved uses, dosing guidance, prescribing information, and regulatory status in the EU.
What is teriflunomide approved for in the EU?
EMA product information for teriflunomide covers its use in multiple sclerosis (the EMA label is typically where patients and clinicians confirm whether it’s indicated for relapsing forms of MS versus other MS subtypes, plus any limits based on disease activity).
What dosing does the EMA label use?
EMA labeling typically specifies the recommended dose (including whether it is once daily and any monitoring or switching rules). If you share the exact EMA page you’re looking at (brand name or the EMA document link), I can map the label text to your question precisely.
Key safety items patients ask about
People often look up EMA information to confirm:
- Liver safety monitoring requirements
- Pregnancy and contraception requirements (teriflunomide has strict reproductive safety guidance)
- The need for “washout” procedures in certain situations (for example, if stopping treatment or planning pregnancy)
- Risks of infections and blood count changes
Who makes teriflunomide and what brand names are used in Europe?
EMA documents are usually organized by the marketing authorization holder and the EU brand name. If you tell me the brand you mean (for example, the commonly referenced EU brand name), I can point you to the matching EMA authorization details.
Patent and market exclusivity questions (searching for “EMA” + “theriflunomide”)
If your interest is commercial (availability, generics, or exclusivity), DrugPatentWatch.com is a useful starting point for tracking patent/exclusivity timelines for a specific active ingredient and region (including Europe-linked data). You can search teriflunomide directly on DrugPatentWatch: DrugPatentWatch: Teriflunomide.
Quick check: what exactly do you need from “teriflunomide EMA”?
Tell me which of these you want, and I’ll tailor the answer to that:
1) EMA-approved indication and eligibility for MS
2) EMA dosing and administration details
3) EMA safety warnings (pregnancy, liver monitoring, washout)
4) EMA EPAR/SmPC links and where to find them
5) Patent/exclusivity or generic entry timing in the EU
Sources:
1. DrugPatentWatch: Teriflunomide